Annual conference features presentations, panels, discussions and networking

Managed Markets Insight & Technology (MMIT)

publications Drug Approvals: November 2024 Critical updates in an ever-changing environment This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a...

Dinesh Kandanchatha joined the organization July 1.

publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...

Expert Clinical Network Insights Metastatic Synovial Sarcoma October 21, 2024 Medication insights: afamitresgene autoleucel (Tecelra) The U.S. Food and Drug Administration (FDA) approved...

publications Carting away REMS and the impact on CAR T utilization August 19, 2025 Author: Simone Ndujiuba, PharmD, BCOP On June 26, 2025, the US Food and Drug Administration (FDA) removed...

publications Built for speed: the evolving landscape of oncology trials November 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP Innovations in clinical trial design have significantly shortened...

Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: September 2025 Prime Careers Spotlight: September 2025 Check out our latest job openings. Together, we can...

Start a medication therapy management internship Get hands-on pharmacy experience and develop leadership, strategic-planning and patient care skills with our medication therapy management and...

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

oncology insights Decoding Cancer: How Genetic and Genomic Testing Advance Treatment December 13, 2024 Scientists have made remarkable progress in understanding the thousands of genes inside our...

cover image for MPTR blog Prime expert shares exciting enhancement to Medical Pharmacy Trend Report Lisa Polakowski Lisa Polakowski, PharmD, is the Medical Pharmacy Trend Report director for Prime...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

Perspectives Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage Approximately 83,000 new bladder cancer cases are diagnosed in the U.S. in each...

PUBLICATIONS Ophthalmology August 13, 2025 Medication insights: teprotumumab-trbw (Tepezza) The U.S. Food and Drug Administration (FDA) first approved teprotumumab-trbw (Tepezza) in January 2020...

publications Radiopharmaceutical discovery and use is gaining momentum March 14, 2025 Author: Abby Kim, PharmD, BCOP Introducing Abby Kim, PharmD, BCOP Abby Kim, a Board-Certified Oncology...

Oncology Insights: Transformative treatment for small cell lung cancer After decades of research, a new treatment is emerging for this aggressive form of lung cancer. By: Simone Ndujiuba, PharmD,...

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...

Learn how Prime champions cancer care through its industry-leading solutions, clinical insights, charitable giving and volunteer efforts